Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to potential participation in the trial, or to replace the advice of a personal physician or health professional.
Histologically or cytologically documented metastatic, measurable adenocarcinoma of the colon, rectum, or appendix with no prior therapies for metastatic disease
ECOG performance status (PS) of 0 or 1
Adequate hematologic, renal, and hepatic function as defined by required baseline laboratory parameters
No other serious concomitant disease.
You may not be if
Peripheral neuropathy \> Grade 1 at baseline
History of significant cerebrovascular, cardiovascular, or peripheral vascular disease
Uncontrolled hypertension (defined as blood pressure \> 150/100 mmHg)
History of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess, within 6 months prior to start of study drug
Minor surgical procedure, fine needle aspiration, or core biopsy within 7 days prior to start of study drug
Serious, non-healing wound, ulcer, or bone fracture
Active gastroduodenal ulcer
Evidence of bleeding diathesis or coagulopathy
Significant history of bleeding within 6 months prior to registration
Prior history of hypertensive crisis or hypertensive encephalopathy
Clareo Health | CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer
